The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 72, Issue 1, 1991, Pages 96-107

  Groop, Leif C ^a   Saloranta, Carola ^a   Shank, Myron ^c   Bonadonnaj, Riccardo C ^c   Ferrannini, Eleuterio ^b   Defronzo, Ralph A ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGE; OBESITY; OBESITY IN DIABETES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025963777     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-72-1-96     Document Type: Article

References (53)

1. Rabinovitz D, Zierler KL. Forearm metabolism in obesity and its response to intra-arterial insulin. J Clin Invest. 1962;41:2173.
2. Harrison LC, Martin FIR, Melick RA. Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J Clin Invest. 1976;58:1435-41.
3. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P. Insulin binding to monocytes and insulin sensitivity in human obesity, starvation, and refeeding. J Clin Invest. 1978;62:204.
4. Kolterman OG, Insel J, Saekow M, Olefsky JO. Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest. 1980;65:1272.
5. Bogardus C, Lillioja S, Mott D, Reaven GM, Kashiwagi A, Foley JE. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest. 1984;73:800.
6. Hollenbeck CB, Chen Y-DI, Reaven GM. A comparison of the relative effects of obesity and non-insulin dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization. Diabetes. 1980;33:622.
7. DeFronzo RA. The triumvirate: β-cell, muscle and liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667.
8. Kolterman OG, Gray RS, Griffin J, et al. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest. 1981;68:957.
9. Bogardus C, Lillioja S, Howard BV, Reaven GM, Mott D. Relationship between insulin secretion, insulin action, and fasting plasma glucose concentration in non-diabetic and non-insulin dependent diabetic subjects. J Clin Invest. 1984;74:1238.
10. Lillioja S, Mott DM, Zawadski JK, Young AA, Abbott WG, Bogardus C. Glucose storage is a major determinant of in vivo “insulin resistance” in subjects with normal glucose tolerance. J Clin Endocrinol Metab. 1986;62:922.
11. Golay A, DeFronzo RA, Ferrannini E, et al. Oxidative and nonoxidative glucose metabolism in non-obese type 2 (non-insulindependent) diabetic patients. Diabetologia. 1988;31:585-95.
12. Golay A, Felber JP, Jeqier E, DeFronzo RA, Ferrannini E. Metabolic bases of obesity and non-insulin dependent diabetes mellitus. Diabetes/Metab Rev. 1988;4:727-47.
13. Groop LC, Bonadonna RC, DelPrato S, et al. Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989;84:205.
14. Arner P, Bolinder J, Engfeldt P, Östman J. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation. Metabolism. 1981;30:753.
15. Howard BV, Savage PJ, Nagulesparan M, Bennion LJ, Unger RH, Bennett P. Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity onset diabetics. Metabolism. 1979;28:744.
16. Lönnroth P, DiGirolamo M, Krotkiewski M, Smith U. Insulin binding and responsiveness in fat cells from patients with reduced glucose tolerance and type II diabetes. Diabetes. 1983;32:748.
17. Howard BV, Klimes I, Vasquez B, Brady D, Nagulesparan M, Unger RH. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. J Clin Endocrinol Metab. 1984;58:544.
18. Bierman EL, Dole VP, Roberts TN. An abnormality of nonesteri-fied fatty acid metabolism in diabetes mellitus. Diabetes. 1957;6:475.
19. Golay A, Swislocki ALM, Chen Y-DI, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acids, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab. 1986;63:481.
20. Golay A, Swislocki ALM, Chen Y-DI, Reaven GM. Relationships between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin dependent diabetic individuals. Metabolism. 1987;36:692.
21. Fraze E, Donner CC, Swislocki ALM, Chiou Y-AM, Chen Y-DI, Reaven GM. Ambient plasma free fatty acid concentrations in non-insulin dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1985;61:807.
22. Gomez F, Jequier E, Chabot V, Bueber V, Felber JP. Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose. Metabolism. 1972;21:381.
23. Meylan M, Henny C, Temler E, Jequier E, Felber JP. Metabolic factors in the insulin resistance in human obesity. Metabolism. 1987;36:256.
24. Felber JP, Ferrannini E, Golay A, et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type 2 diabetes. Diabetes. 1987;36:1341.
25. Lillioja S, Bogardus C, Mott DM, Kennedy AL, Knowler WC, Howard BV. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J Clin Invest. 1985;75:1106.
26. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle. Its role in insulin insensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785.
27. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214.
28. Issekutz Jr B, Bortz WM, Miller HI, Paul P. Turnover rate of plasma FFA in human and in dogs. Metabolism. 1967;16:1001.
29. Issekutz Jr B, Paul P, Miller HI, Bortz WM. Oxidation of plasma FFA in lean and obese humans. Metabolism. 1967;17:62.
30. Ferrannini E. The theoretical basis of indirect calorimetry: a review. Metabolism. 1988;37:287.
31. Coleman TG, Manning Jr RD, Norman Jr RA, Guyton AC. Dynamics of water-isotope distribution. Am J Physiol. 1972;223:1371.
32. Altzuler N, Barkai A, Bjerknes A, Gottlieb B, Steele R. Glucose turnover values in the dog obtained with various species of labeled glucose. Am J Physiol. 1975;225:1662.
33. Hales CN, Randle PJ. Immunoassay of insulin with antibody precipitate. Biochem J. 1963;88:137.
34. Hawk PD. Kjeldahl method 1947. In: Practical physilogical chemistry, 12th ed. Toronto: Blakiston; 1947;814-22.
35. Miles JR, Glassock J, Aikens J, Gerich J, Haymond M. A micro-fluorometric method of free fatty acids in plasma. J Lipid Res. 1983;24:96.
36. Radziuk J, Norwich KH, Vranic M. Measurements and validation of non-steady state turnover rates with application to the insulin and glucose systems. Fed Proc. 1974;33:1855.
37. Cobelli C, Mari A, Ferrannini E. Non-steady state: error analysis of Steele’s model and development for glucose kinetics. Am J Physiol. 1987;252:E679.
38. Hagenfeldt L. Turnover of individual free fatty acids in man. Fed Proc. 1975;34:2246.
39. Hagenfeldt L, Wahren J, Pernow B, Raf L. Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest. 1972;51:2324.
40. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physilogical dose-response curves. Am J Physiol. 1978;235:E97.
41. Kahn CR. Insulin resistance, insulin insensivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978;27(Suppl 2):1893.
42. DeFronzo RA. Glucose tolerance and aging. Evidence for tissue insenstivity to insulin. Diabetes. 1979;28:1039.
43. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, DelPrato S, DeFronzo RA. Obesity and insulin resistance in man. A dose response study. Metabolism. 39:452-459, 1990.
44. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin dependent diabetes mellitus. Metabolism. 1988;37:15.
45. Cherrington AD, Williams PE, Harris MS. Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism. 1978;27:787.
46. Henry RR, Wallace P, Olesky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin dependent diabetes mellitus. Diabetes. 1986;35:990.
47. Nurjhan N, Campbell PJ, Kennedy FP, Miles JM, Gerich JE. Insulin dose response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes. 1986;35:1326.
48. Issekutz Jr B, Miller HI, Paul P, Rodahl K. Source of fat oxidation in exercising dog. Am J Physiol. 1964;207:583.
49. Dagenais GR, Tancredi RG, Zierler KL. Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest. 1976;58:421.
50. Robin AP, Nordenstrom J, Askanzi J, Carpentier YA, Elwyn DH, Kinney JM. Influence of parenteral carbohydrate on fat oxidation in surgical patients. Surgery. 1984;95:608.
51. Fritz IB. Factors influencing the rates of long chain fatty acid oxidation and synthesis in mammalian systems. Physiol Rev. 1961;41:52.
52. Groop L, Bonadonna RC, Petrides AS, DeFronzo RA: Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest. In Press.
53. Tessari P, Nilsson SL, Miles JM, Haymond MW. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest. 1986;77:575.